NYSE:RAMPLiveRamp Stock Price, Forecast & News

LiveRamp's stock was trading at $29.30 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RAMP shares have increased by 52.4% and is now trading at $44.64. View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LiveRamp in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for LiveRamp.

LiveRamp is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for LiveRamp.

LiveRamp Holdings (NYSE:RAMP) posted its quarterly earnings results on Thursday, May, 21st. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.14) by $0.09. The firm earned $105.70 million during the quarter, compared to analysts' expectations of $100.02 million. LiveRamp had a negative net margin of 32.72% and a negative return on equity of 10.07%. The firm's quarterly revenue was up 35.0% compared to the same quarter last year. During the same quarter last year, the business earned ($0.13) earnings per share. View LiveRamp's earnings history.

LiveRamp updated its first quarter 2021 After-Hours earnings guidance on Thursday, May, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $88-88 million, compared to the consensus revenue estimate of $101.14 million.

6 brokers have issued 12 month target prices for LiveRamp's stock. Their forecasts range from $40.00 to $63.00. On average, they expect LiveRamp's share price to reach $55.33 in the next twelve months. This suggests a possible upside of 24.0% from the stock's current price. View analysts' price targets for LiveRamp.

Media headlines about RAMP stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. LiveRamp earned a daily sentiment score of 0.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the near term. View the latest news about LiveRamp.

Some companies that are related to LiveRamp include StoneCo (STNE), Zendesk (ZEN), Autohome (ATHM), Zynga (ZNGA), Clarivate Analytics (CCC), Pegasystems (PEGA), YY (YY), Five9 (FIVN), Proofpoint (PFPT), Globant (GLOB), Corelogic (CLGX), DXC Technology (DXC), Change Healthcare (CHNG), Inovalon (INOV) and CarGurus (CARG). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other LiveRamp investors own include Alibaba Group (BABA), NVIDIA (NVDA), Johnson & Johnson (JNJ), Paypal (PYPL), AbbVie (ABBV), DexCom (DXCM), Lowe's Companies (LOW), AT&T (T), Vertex Pharmaceuticals (VRTX) and Beyond Meat (BYND).

LiveRamp trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAMP."

Shares of RAMP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of RAMP stock can currently be purchased for approximately $44.64.

LiveRamp has a market capitalization of $2.93 billion and generates $380.57 million in revenue each year. The company earns $-124,510,000.00 in net income (profit) each year or ($1.85) on an earnings per share basis. LiveRamp employs 1,150 workers across the globe.

The official website for LiveRamp is www.liveramp.com.

LiveRamp's mailing address is 225 Bush Street Seventeenth Floor, San Francisco CA, 94104. The company can be reached via phone at 866-352-3267 or via email at [email protected]